Richard P Steeds
Overview
Explore the profile of Richard P Steeds including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
2858
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Church Smith C, Roy A, Steeds S, Tuzcuoglu N, Wingrove C, Aitchison K, et al.
Mol Genet Metab Rep
. 2025 Feb;
42:101194.
PMID: 39897472
Fabry disease (FD) is a rare, pan ethnic X-linked disorder. We explored ethnic representation in our service and a national patient organisation. An audit of the University Hospitals Birmingham FD...
2.
Aljehani A, Win K, Baig S, Kalla M, Ensam B, Fabritz L, et al.
J Cardiovasc Dev Dis
. 2024 Dec;
11(12).
PMID: 39728277
Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic disorder associated with an elevated risk of life-threatening arrhythmias and progressive ventricular impairment. Risk stratification is essential to prevent major...
3.
Lodge F, Moody W, McAloon C, Stoll V, Mahmoud-Elsayed H, Steeds R, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
10:100411.
PMID: 39713601
Introduction: Right ventricular size and function on cardiac MRI provides thresholds for referral for pulmonary valve intervention in repaired Tetralogy of Fallot (RTOF). However, different contouring techniques are available to...
4.
Ioannou A, Razvi Y, Porcari A, Rauf M, Martinez-Naharro A, Venneri L, et al.
JAMA Cardiol
. 2024 Nov;
10(1):50-58.
PMID: 39550765
Importance: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive cardiomyopathy that commonly presents with concomitant chronic kidney disease. Chronic kidney dysfunction is associated with worse outcomes, but the prognostic value of...
5.
Naneishvili T, Yuan M, Mansour M, Moody W, Steeds R
JACC Case Rep
. 2024 Nov;
29(19):102609.
PMID: 39484338
No abstract available.
6.
Patel L, Roy A, Barlow J, OShea C, Nieves D, Azad A, et al.
Mol Genet Metab
. 2024 Sep;
143(1-2):108575.
PMID: 39243575
Alström syndrome (AS) is an inherited rare ciliopathy characterised by multi-organ dysfunction and premature cardiovascular disease. This may manifest as an infantile-onset dilated cardiomyopathy with significant associated mortality. An adult-onset...
7.
Samat A, Cassar M, Akhtar A, McCracken C, Ashkir Z, Mills R, et al.
Int J Cardiol
. 2024 Aug;
415:132415.
PMID: 39127146
Background: The role of ECG in ruling out myocardial complications on cardiac magnetic resonance (CMR) is unclear. We examined the clinical utility of ECG in screening for cardiac abnormalities on...
8.
Roy A, Patel L, Yuan M, OShea C, Alvior A, Charalambides M, et al.
Int J Cardiol
. 2024 Aug;
414:132437.
PMID: 39127143
No abstract available.
9.
Kwok C, Choy C, Pinney J, Townend J, Whelan C, Fontana M, et al.
ESC Heart Fail
. 2024 Jul;
11(6):3901-3910.
PMID: 39041492
Aims: The efficacy of beta-blockers in cardiac amyloidosis (CA) is unclear, and concerns persist that neurohormonal blockade could worsen symptoms of heart failure. We aimed to assess whether beta-blocker therapy...
10.
Naneishvili T, Yuan M, Mansour M, Moody W, Steeds R
JACC Case Rep
. 2024 Jul;
29(14):102408.
PMID: 38994527
Costello syndrome is an autosomal dominant condition caused by variants in the gene. Cardiac presentation includes valvular disease (usually valvar pulmonary stenosis), arrhythmias, and hypertrophic cardiomyopathy. To our knowledge, this...